Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin for urinary symptoms associated with indwelling double-J ureteral stents
ACTRN12611000569909Phase 4Completed
- Sponsor
- Chung Jing Wang
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ureteral stent-related symptoms (USRS) comparing Silodosin with Placebo (2 arms). Primary endpoints: Ureteral Stent Symptom Questionnaire score and International Prostate Symptom Score quality of life. Started Nov 2010; status: completed.
02
Drugs
silodosin
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on ACTRN12611000569909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000569909.